Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Sales | 319,047 | 305,989 | 452,845 | 424,130 | 344,809 |
| Total expenses | 273,127 | 272,573 | 238,132 | 215,370 | 136,339 |
| Operating Income | 45,920 | 33,416 | 214,713 | 208,760 | 208,470 |
| Interest Income | 10,377 | 6,786 | N/A | N/A | N/A |
| Interest Expense | 63,789 | 48,188 | 48,589 | 52,049 | 41,893 |
| Other Income | -37,956 | -170,624 | 0 | 0 | 0 |
| Pre-tax Income | -55,825 | -185,396 | 166,124 | 156,711 | 166,577 |
| Income Tax | -12,045 | -6,007 | 78,898 | 85,124 | 84,654 |
| Net Income Continuous | -43,780 | -179,389 | 87,226 | 71,587 | 81,923 |
| Net Income | $-43,780 | $-179,389 | $87,226 | $71,587 | $81,923 |
| EPS Basic Continuous Ops | -0.73 | -3.01 | 1.48 | 1.29 | 1.70 |
| EPS Basic Total Ops | -0.77 | -3.08 | 1.36 | 1.15 | 1.70 |
| EPS Diluted Continuous Ops | -0.73 | -3.01 | 1.46 | 1.26 | 1.69 |
| EPS Diluted Total Ops | -0.77 | -3.08 | 1.34 | 1.13 | 1.69 |
| EBITDA(a) | $103,617 | $219,594 | $232,081 | $249,973 | $229,857 |